奥里辛A对杆菌的抗菌活性及其对上皮细胞的保护作用
Thotsaporn Bunthiang1, Siriwan Sunontarat1, Nattamol Phetburom1
1Faculty of Public Health, Kasetsart University Chalermphrakiat Sakon Nakhon Province Campus, Sakon Nakhon 47000, Thailand.
International journal of molecular sciences
|February 27, 2026
概括
Aurisin A是一种来自Neonothopanus nambi的化合物,它对Streptococcus suis.表现出强大的抗菌活性. 它有效地抑制了细菌的生长,生物膜的形成,并减少了毒性因素,为治疗猪和人类的S. suis感染提供了一个有希望的替代方案.
科学领域:
- 自然产品化学 自然产品化学
- 微生物学 微生物学
- 传染性疾病 传染性疾病
背景情况:
- 瑞杆菌 (Streptococcus suis) 是一种影响猪和人类的动物性病原体.
- 越来越多的抗菌素耐药性在S. suis需要新的治疗策略.
- 奥里辛A是一种来自Neonothopanus nambi的基烯,因其抗菌潜力而受到探索.
研究的目的:
- 为了评估 aurisin A 对瑞士链球菌的疗效.
- 调查奥里辛A抗菌活性背后的机制.
- 评估Aurisin A作为S. suis感染的治疗剂的潜力.
主要方法:
- 确定最小的抑制 (MIC) 和杀菌 (MBC) 度.
- 扫描电子显微镜 (SEM) 用于细胞结构分析.
- 用于生物膜抑制试验的水晶紫色染色.
- 在体外测试中使用肺上皮细胞和绵羊血来评估抗粘附性,抗细胞毒性和抗血解活性.
主要成果:
- 奥里辛A对S. suis菌株具有显著的抗菌活性,其MIC/MBC范围为1.94-62.5μg/mL.
- 在S. suis.中,SEM揭示了aurisin A诱导的细胞表面纹,泄漏和溶解.
- 奥里辛A有效抑制了S. suis生物膜的形成,并降解了预先形成的生物膜.
- 奥里辛A降低了肺上皮细胞中的细菌粘附,细胞毒性和细胞死亡,降低了血液溶解活性.
结论:
- 奥里辛A表现出广泛的抗菌活性,可对抗瑞士链球菌.
- 奥里辛A破坏了细菌细胞的完整性,并抑制了关键的毒性因素,如生物膜形成和血液溶解.
- 奥里辛A是一种有前途的治疗候选药物,用于管理S. suis感染,因为它对宿主细胞具有多方面的保护作用.
相关概念视频
Surface Membrane Barriers
3.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.1K
Antimicrobial Proteins
14.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.8K
Antimicrobial Effectiveness
1.4K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.4K
Gene Regulation in Microbial Communities: Quorum Sensing
767
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
767
Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.8K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.8K


